What are the clinical features, diagnostic workup, and management recommendations for juvenile nephronophthisis?

Juvenile Nephronophthisis: Clinical Features, Diagnosis, and Management

Juvenile nephronophthisis is an autosomal recessive ciliopathy that presents insidiously with polyuria and polydipsia in school-age children, progressing to end-stage renal disease by the second decade, and requires early recognition through genetic testing since imaging and urinalysis are often deceptively normal.

Clinical Features

Typical Presentation

The disease manifests after age 6 years through adolescence with an insidious onset that frequently delays diagnosis 1, 2. The hallmark early symptoms include:

• Polyuria and polydipsia due to urine concentration defects starting in the first decade
• Anemia disproportionate to the degree of renal dysfunction
• Growth retardation
• Notably absent: hypertension and edema - this absence often misleads clinicians and delays diagnosis 3, 2

Critical Diagnostic Pitfall

The urinalysis is typically normal or shows only mild proteinuria in most patients 4. Six of 13 confirmed cases in one series had mild-to-moderate proteinuria, while seven had completely normal urinalysis 4. Persistent hematuria is absent 4. This benign urinalysis in the setting of progressive renal failure is a key distinguishing feature that paradoxically contributes to delayed recognition.

Extrarenal Manifestations

Approximately 10-15% of patients present with associated features 1:

• Retinitis pigmentosa (Senior-Løken syndrome) - most common association
• Hepatic fibrosis
• Cerebellar ataxia
• Mental retardation
• Skeletal abnormalities

Diagnostic Workup

Imaging Characteristics

Renal ultrasound findings are characteristically subtle and often misleading 5, 6:

• Increased echogenicity with loss of corticomedullary differentiation is the most consistent finding (present in 10 of 11 patients at presentation) 5
• Cysts are frequently absent at initial presentation - only 2 of 11 patients had visible cysts initially 5
• Cysts typically develop after progression to end-stage renal disease and may appear years later on follow-up imaging 1, 5
• Kidney size remains normal in many patients (4 of 7 in one series) 6
• When present, cysts are 1-15 mm, located at the corticomedullary junction, and seen in only 70% of cases 3

The absence of cysts does not rule out nephronophthisis - this is a critical point that distinguishes it from other cystic kidney diseases 5.

Genetic Testing - The Definitive Diagnostic Approach

Genetic testing should be pursued early rather than waiting for characteristic imaging findings 1, 4:

• NPHP1 gene defects account for approximately 25% of cases and should be tested first 4
• Large homozygous deletions and point mutations both occur
• If eye involvement is present, test NPHP5 first, then NPHP10 and NPHP1 4
• Eight genes (NPHP1, 3,4,5,6,7,8,9) cause juvenile forms; NPHP2 causes infantile forms 1
• Genetic heterogeneity exists between populations - Chinese patients show lower rates of homozygous deletions compared to Western populations 4

Renal Biopsy Findings

When performed, histology shows 1, 3:

• Chronic tubulointerstitial nephritis
• Tubular basement membrane thickening and layering
• Tubular atrophy
• Interstitial fibrosis
• Corticomedullary cysts (when present)

Management Recommendations

Monitoring and Supportive Care

Since no specific disease-modifying therapy exists, management focuses on:

• Early recognition to optimize timing of renal replacement therapy
• Management of anemia (often more severe than expected for GFR)
• Growth hormone therapy consideration for growth retardation
• Adequate hydration to compensate for concentration defects
• Avoidance of nephrotoxic medications

Renal Replacement Therapy

These children are excellent candidates for kidney transplantation 2. The disease does not recur in the transplanted kidney. Early planning for transplantation is appropriate given the predictable progression to ESRD by the second decade.

Family Counseling

• Autosomal recessive inheritance pattern requires genetic counseling for families
• 25% recurrence risk for future siblings
• Currently no reliable method for heterozygote detection or prenatal diagnosis exists 3
• Ophthalmologic screening should be performed to identify Senior-Løken syndrome

Key Clinical Algorithm

For any child presenting with:

1. Polyuria/polydipsia after age 6
2. Unexplained anemia
3. Progressive renal insufficiency
4. Normal or near-normal urinalysis
5. Absence of hypertension

→ Obtain renal ultrasound looking for increased echogenicity and loss of corticomedullary differentiation

→ Proceed directly to genetic testing (NPHP1 first, or NPHP5 if retinal involvement) rather than waiting for cysts to develop

→ Screen for extrarenal manifestations (ophthalmology, liver function)

→ Plan early for renal replacement therapy

The combination of progressive renal failure with benign urinalysis and absent hypertension in a school-age child should immediately raise suspicion for nephronophthisis, prompting genetic rather than imaging-based diagnosis 1, 4, 5.